PharmaCielo FY26 net loss narrows to C$ 3.58 million; revenue falls to C$ 2.54 million

PUBT · 2d ago
PharmaCielo FY26 net loss narrows to C$ 3.58 million; revenue falls to C$ 2.54 million
  • PharmaCielo posted Q4 revenue of CAD 719,000, up 47.64% year over year; net loss narrowed to CAD 1.3 million from CAD 2.2 million.
  • Q4 gross profit swung to CAD 279,000 from a CAD 264,000 gross loss a year earlier; IFRS adjusted EBITDA loss tightened to CAD 620,000 from CAD 801,000.
  • For the year ended March 31, 2026, revenue fell to CAD 2.54 million; net loss narrowed to CAD 3.58 million from CAD 11.37 million.
  • Full-year gross profit rose to CAD 725,000 from CAD 467,000; IFRS adjusted EBITDA loss improved to CAD 2.57 million from CAD 3.54 million.
  • Sold the La Margarita property for about CAD 10 million, booking a CAD 2.2 million gain; management said Colombia subsidiaries turned cash-flow positive at the operating level.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmacielo Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607300800NEWSFILECNPR____20260730_307203_1) on July 30, 2026, and is solely responsible for the information contained therein.